TABLE 3.
Application | Name | Sequence and restriction sitea |
---|---|---|
Construction of pT7-7 StrepIIVirB5 | VirB5-5′ | 5′-CAGGGTACCCAGTTCGTTGTCAGCGATCCGGCG-3′ |
and pT7-7H6TrxA-VirB5 | VirB5-3′ | 5′-GAGCTGCAGTCAGGGGACGGCCCCAAAGATG-3′ |
Construction of pAS2-Tzs and | AS2-Tzs-5′ | 5′-GGAGGCTCATGATACTCCATCTCATCTACGGACC-3′ |
pACTII-Tzs | AS2-Tzs-3′ | 5′-GACGGGGATCCTCACCGAATTCGCGTCAGCGTG-3′ |
Cloning of virB2 | B2-5 | 5′-CCACACGAATTCCAAGTCGTGATGGACCGTCTCGA-3′ |
B2-3 | 5′-CCACACGAATTCGACGGCAACGTGCATTGCGCATTT-3′ | |
Deletion of virB2 | ΔB2-5 | 5′-AGGAGGTCCGCAATAATGAATGATCGTCTGGAAGCAACCCTT-3′ |
ΔB2-3 | 5′-TTATTGCGGACCTCCTTGATTTAAGTCGAACAAGAGTTGATCGTC-3′ | |
Cloning of virB8 | B8-5 | 5′-CGCAGTCTAGAGCAAAGTGGATCGGGCAACTTAT-3′ |
B8-3 | 5′-CGCAGTCTAGACCTCTGCTCTCTGTTGATATTGCGCTT-3′ | |
Deletion of virB8 | ΔB8-5 | 5′-CCGTGCTCGAGTTATTCAGACCCCTTCATGGCGACCACCT-3′ |
ΔB8-3 | 5′-CCGTGCTCGAGATGACGAAAAAAGCATTTCTCA-3′ |
Restriction enzyme cleavage sites are underlined.